The major problem in the field of transplantation is the lack of human organs and tissues for those who need them. This problem is so severe that by some estimates only 5-15 percent of the organ transplants needed is carried out. One approach to overcoming this problem is to use animal organs in lieu of human organs for transplantation, that is xenotransplantation. While xenotransplantation could in principle solve the problem of the shortage of organs, it is not presently feasible because the immune system of the recipient reacts severely with the graft. The first manifestation of this reaction is hyperacute rejection. Triggered by the binding of xenoreactive antibodies and the activation of complement, hyperacute rejection can now be overcome by various means including the use of pigs expressing human complement regulatory proteins as the source of xenografts. When hyperacute rejection is averted, a xenograft is subject to acute vascular rejection. Acute vascular rejection destroys organ xenografts over a period of days to weeks. It appears to be caused by antibodies in the recipient, which bind to blood vessels in the graft causing activation of endothelial cells and tissue injury that ensues. Fortunately, acute vascular rejection is not an invariable outcome of organ xenografts. Under some conditions, such as when xenoreactive antibodies are temporarily depleted, a graft may seemingly acquire resistance to injury by anti-donor antibodies, a condition referred to as accommodation. This application proposes studies that will elucidate the nature of the xenoreactive antibodies that cause acute vascular rejection of cardiac xenografts and determine how antibodies or other factors reacting with a graft may induce accommodation. Studies will be conducted in a model system in which porcine hearts are transplanted heterotopically into baboons. The antibodies produced by the baboons in response to the porcine organs will be studied at the time that acute vascular rejection or accommodation occurs. The specificity of those antibodies, number of antigens and frequency in pigs will be determined and the mechanisms by which those antibodies or other factors induce changes in endothelial cells will be ascertained. These experiments will provide information critical to the devising of new strategies for preventing acute vascular rejection or promoting the occurrence of accommodation of cardiac xenografts.
| Platt, Jeffrey L; Zhou, Xiaofeng; Lefferts, Adam R et al. (2016) Cell Fusion in the War on Cancer: A Perspective on the Inception of Malignancy. Int J Mol Sci 17: |
| Zhou, Xiaofeng; Merchak, Kevin; Lee, Woojin et al. (2015) Cell Fusion Connects Oncogenesis with Tumor Evolution. Am J Pathol 185:2049-60 |
| Platt, Jeffrey L; Cascalho, Marilia (2015) IgM in the kidney: a multiple personality disorder. Kidney Int 88:439-41 |
| Tsuji, Shoichiro; Stein, Lucas; Kamada, Nobuhiko et al. (2014) TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen. J Clin Invest 124:4857-66 |
| Cascalho, Marilia I; Chen, Brian J; Kain, Mandy et al. (2013) The paradoxical functions of B cells and antibodies in transplantation. J Immunol 190:875-9 |
| Lynch, R J; Silva, I A; Chen, B J et al. (2013) Cryptic B cell response to renal transplantation. Am J Transplant 13:1713-23 |
| Platt, J L (2011) Accommodation: how you see it, how you don't. Am J Transplant 11:2007-8 |
| McConico, Andrea; Butters, Kim; Lien, Karen et al. (2011) In utero cell transfer between porcine littermates. Reprod Fertil Dev 23:297-302 |
| Tsuji, Shoichiro; Cortesão, Catarina; Bram, Richard J et al. (2011) TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow. Blood 118:5832-9 |
| Zhou, Xiaofeng; Platt, Jeffrey L (2011) Molecular and cellular mechanisms of mammalian cell fusion. Adv Exp Med Biol 713:33-64 |
Showing the most recent 10 out of 141 publications
